Related Experiment Video
Updated: Jul 20, 2026

MicroRNA Detection in Prostate Tumors by Quantitative Real-time PCR (qPCR)
Published on: May 16, 2012
Concomitant down-regulation of SPRY1 and SPRY2 in prostate carcinoma
S Fritzsche1, M Kenzelmann, M J Hoffmann
1Department of Urology, Heinrich-Heine University, Düsseldorf, Moorenstr. 5, 40225 Düsseldorf, Germany.
Abstract:
Sprouty proteins encoded by the SPRY genes act as modulators and feedback inhibitors of signalling by epidermal growth factor (EGF) and fibroblast growth factor (FGF). Overactivity of EGF and FGF signalling common in prostate cancer might therefore be exacerbated by Sprouty down-regulation. Indeed, down-regulation of SPRY1 and SPRY2 expression has been independently reported. We found both genes modestly down-regulated by microarray expression analysis of microdissected prostate cancers and by quantitative RT-PCR in macrodissected specimens compared with benign tissues. Importantly, the decreases paralleled each other and expression levels of both genes were significantly lower in cancers that recurred within the average follow-up period of 32 months. In contrast to a previous report, no hypermethylation was found to accompany down-regulation of SPRY2 in cancer tissues and cell lines. We additionally investigated the expression of an SPRY1 alternative transcript presumed to be specific for fetal tissues and found its expression moderately well correlated with expression of the standard transcript through diverse tissues and cell lines. The present study confirms and extends previous reports by demonstrating concomitant down-regulation and a significant association with recurrence of SPRY genes.
Insights
Down-regulation of SPRY genes, which normally inhibit growth factor signaling, is common in prostate cancer. Lower SPRY gene expression correlates with increased cancer recurrence, suggesting a role in disease progression.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Sprouty proteins (SPRY genes) inhibit signaling pathways like epidermal growth factor (EGF) and fibroblast growth factor (FGF).
- Overactive EGF/FGF signaling is prevalent in prostate cancer.
- Previous studies reported down-regulation of SPRY1 and SPRY2 in prostate cancer.
Purpose of the Study:
- To investigate the expression levels of SPRY1 and SPRY2 in prostate cancer tissues.
- To determine if SPRY gene down-regulation correlates with prostate cancer recurrence.
- To examine the methylation status of SPRY2 in cancer tissues.
Main Methods:
- Microarray expression analysis of microdissected prostate cancers.
- Quantitative reverse transcription PCR (RT-PCR) on macrodissected specimens.
- Analysis of SPRY1 alternative transcript expression.
Main Results:
- Both SPRY1 and SPRY2 genes were found to be modestly down-regulated in prostate cancers compared to benign tissues.
- Decreased expression levels of SPRY1 and SPRY2 paralleled each other.
- Significantly lower expression of both SPRY genes was observed in recurrent cancers.
- No hypermethylation was found to be associated with SPRY2 down-regulation.
Conclusions:
- The study confirms and extends previous findings on SPRY gene down-regulation in prostate cancer.
- Concomitant down-regulation of SPRY1 and SPRY2 is associated with prostate cancer recurrence.
- The findings suggest SPRY genes play a role in prostate cancer progression.
Related Concept Videos
Abnormal Proliferation
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

